Autoimmune, cardiovascular/metabolic and psychiatric comorbidities associated with rosacea: a cross-sectional study in the All of Us database
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llae167 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Tejas P Joshi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Rosacea, Comorbidity, Cardiovascular Diseases. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Rosacea is a chronic, common inflammatory skin disorder. However, studies investigating the comorbidities associated with rosacea in a diverse cohort of American patients are lacking. Here, we use the National Institutes of Health All of Us research programme to explore the association of rosacea with autoimmune, cardiovascular and psychiatric comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, Houston, TX, USA.
- Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Tejas P Joshi
Zitieren
APA
Joshi, T. P., Rivera, A., Gedeon, F., & Khalfe, N. (2024). Autoimmune, cardiovascular/metabolic and psychiatric comorbidities associated with rosacea: a cross-sectional study in the All of Us database. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae167
Vancouver
Joshi TP, Rivera A, Gedeon F, Khalfe N. Autoimmune, cardiovascular/metabolic and psychiatric comorbidities associated with rosacea: a cross-sectional study in the All of Us database. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae167
BibTeX
@article{Joshi2024,
author = {Joshi, Tejas P and Rivera, Ana and Gedeon, Francesca and Khalfe, Nasim},
title = {Autoimmune, cardiovascular/metabolic and psychiatric comorbidities associated with rosacea: a cross-sectional study in the All of Us database},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llae167}
}
EUVIMED